Low glucose suspend: Ready for prime time?

Diabetes Technology and Therapeutics

Volumn 14, Issue 3, 2012, Pages 201-202

  Hirsch, Irl B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; DIABETES CONTROL; DISEASE DURATION; DRUG EFFICACY; EDITORIAL; GLYCEMIC CONTROL; HUMAN; INFUSION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN INFUSION; INSULIN PUMP; PATIENT SAFETY; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY;

EID: 84857850421     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0036     Document Type: Editorial

References (12)

1. www.t1dexchange.org/ (accessed February 4, 2012)
2. Hirsch IB: Insulin delivery in the T1D Exchange Clinic Registry: factors associated with pump use, discontinuation, and clinical outcomes. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, Spain, February 10, 2012.
3. Garg SK: Self-monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM), and HbA1c. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, Spain, February 10, 2012.
4. Willi SM: Diabetic ketoacidosis and severe hypoglycemia in relation to pump and sensor use in the T1D Exchange Clinic Registry. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, Spain, February 10, 2012.
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
6. Cryer PE: Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am 2010;39:641-654.
7. Garg S, Brazg RL, Bailey TS, Buckingham BB, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE Study. Diabetes Technol Ther 2012;14:205-209.
8. Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR: Insulin aspart (B28 asp-insulin): a fastacting analog of human insulin: absorption kinetics and action profile compared to human regular insulin in healthy nondiabetic subjects. Diabetes Care 1999;22:1501-1506. (Pubitemid 29418246)
9. Attia N, Jones TW, Holcombe J, Tamborlane WV: Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and treatment of acutely compensated IDDM. Diabetes Care 1998;21:817-821. (Pubitemid 28487078)
10. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
11. Raju B, Arbelaez AM, Breckenridge SM, Cryer PE: Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab 2006; 91:2087-2092. (Pubitemid 43854987)
12. www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm259301.htm (accessed February 4, 2012).